Seeing all this uncertainty priced is very puzzling.
Especially if you consider the incomplete trial made in Europe, where even if incomplete and not comparative, still was showing very good results with very old people.
There the company was worth more than now.
Trade and Clinica Trial Results, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
